Anavex Life Sciences Corp (AVXL)

[Investor2014]

Exactly! Why did Anavex not increase the n of EXCELLENCE even more after the FDA feedback to balance the age groups, while also look at the n of their competitor’s trial.

I am very prone to using Bayesian logic in assessing my chances in biotech investing. It is an advantage to take every new data point/information into account and adjust what chance would look like in the new context - wins over dedicated static WGT any time.